Edition:
United Kingdom

Merrimack Pharmaceuticals Inc (MACK.OQ)

MACK.OQ on NASDAQ Stock Exchange Global Market

6.25USD
22 May 2019
Change (% chg)

$-0.06 (-0.95%)
Prev Close
$6.31
Open
$6.32
Day's High
$6.35
Day's Low
$6.19
Volume
3,329
Avg. Vol
13,218
52-wk High
$10.51
52-wk Low
$3.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.784
FY 2018 Dec '18 0.00 -0.957
Sep '18 0.00 -0.925
Jun '18 0.00 -1.332
Mar '18 0.00 -1.333
FY 2017 Dec '17 0.00 0.605
Sep '17 0.00 -0.403
Jun '17 0.00 -2.184
Mar '17 0.00 -2.201
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 93.91 35.38
P/E High - Last 5 Yrs. -- 165.96 57.42
P/E Low - Last 5 Yrs. -- 52.33 28.05
Beta 2.33 1.21 0.95
Price to Sales (TTM) -- 40.46 9.11
Price to Book (MRQ) 1.72 11.64 4.14
Price to Tangible Book (MRQ) 1.72 16.93 4.92
Price to Cash Flow (TTM) -- 61.69 24.31
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.66
Dividend Yield - 5 Year Avg -- 0.05 0.72
Dividend 5 Year Growth Rate -- 0.93 3.09
Payout Ratio(TTM) -- 1.44 15.30

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 60.11 16.47
Sales (TTM) vs TTM 1 Yr. Ago -- 46.73 8.25
Sales - 5 Yr. Growth Rate -- 33.01 10.28
EPS (MRQ) vs Qtr. 1 Yr. Ago 41.19 -9.49 20.19
EPS (TTM) vs TTM 1 Yr. Ago -20.63 -- --
EPS - 5 Yr. Growth Rate -- 22.33 7.21
Capital Spending - 5 Yr. Growth Rate -58.73 25.09 8.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.78 2.42
Current Ratio (MRQ) 5.39 3.84 3.35
LT Debt to Equity (MRQ) 27.61 7.66 14.41
Total Debt to Equity (MRQ) 30.62 20.75 19.82
Interest Coverage (TTM) -2.73 32.39 14.76

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 24.20 50.33
Gross Margin - 5 Yr. Avg. -- 54.82 51.09
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -477.30 -16.15 15.82
Operating Margin (TTM) -- -117.60 -4.67
Operating Margin - 5 Yr. Avg. -495.50 -31.97 11.06
Pre-Tax Margin (TTM) -- -117.82 -5.05
Pre-Tax Margin - 5 Yr. Avg. -586.60 -34.47 15.86
Net Profit Margin (TTM) -- -123.43 -8.82
Net Profit Margin - 5 Yr. Avg. -494.60 -39.41 11.12
Effective Tax Rate (TTM) -- 17.13 19.88
Effective Tax Rate - 5 Yr. Avg. -- 18.93 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 9,095,320 745,968,214
Net Income/Employee (TTM) -1,975,667 1,694,799 87,116,556
Receivable Turnover (TTM) -- 11.62 5.67
Inventory Turnover (TTM) -- 2.44 3.64
Asset Turnover (TTM) 0.00 0.33 0.79

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -62.08 6.20 9.45
Return on Assets - 5 Yr. Avg. -69.37 6.13 10.45
Return on Investment (TTM) -74.87 7.62 11.72
Return on Investment - 5 Yr. Avg. -135.67 8.01 13.31
Return on Equity (TTM) -83.21 8.12 16.38
Return on Equity - 5 Yr. Avg. -- 9.07 14.87
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -9.50 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Merrimack Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 3.78 6.29 75 4
13 Week 6.41 3.27 66 10
26 Week 38.99 28.19 81 7
52 Week -27.47 -30.80 50 14
YTD 63.47 43.07 83 4
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 51.27%
# of Holders: 61
Total Shares Held: 6,840,870
3 Mo. Net Change: -1,081,741
# New Positions: 6
# Closed Positions: 11
# Increased Positions: 22
# Reduced Positions: 29
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.